Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAcid reflux and indigestion are recognised side effects of Mounjaro (tirzepatide). Clinical trial data show upper gastrointestinal symptoms — including heartburn, burping and reflux — affect a meaningful proportion of people, particularly in the first weeks of treatment or after a dose increase. These are prescription-only medicines; a GPhC-registered prescriber assesses whether they are suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults over 72 weeks and recorded gastrointestinal events as the most frequently reported side effects across all tirzepatide doses. Nausea and vomiting led the list, but indigestion, reflux and excessive burping were also consistently reported, more so at higher doses and during the early weeks of each dose step. This pattern makes biological sense. Tirzepatide works partly by slowing gastric emptying: food and stomach acid sit in the stomach for longer, which raises the chance that acid travels upward into the oesophagus. The NHS medicines page for tirzepatide lists indigestion and burping directly alongside nausea as common effects. So if you want a fuller picture of why this happens and how common it really is, our dedicated page on Mounjaro and acid reflux covers the mechanism and what most people experience. You are not having an unusual reaction. You are experiencing a documented, mechanistically predictable response to how the medicine works.
That said, frequency is not the same as inevitability. Not everyone gets reflux, and among those who do, severity varies considerably. Mild, intermittent heartburn after eating is very different from persistent daily symptoms that affect sleep or nutrition.
Mounjaro is introduced at 2.5 mg, a dose designed to let your digestive system adapt gradually before the dose steps up. Each increase, typically every four weeks under prescriber guidance, asks the stomach to adjust again. Many people find their reflux reappears or worsens for a short period after moving to a new dose, then settles. This is the same pattern seen with nausea: a temporary heightening, not a permanent new baseline. Our overview of Mounjaro side effects covers the broader picture of how GI symptoms change over the course of treatment.
If reflux is hitting hardest at night, that is a specific pattern worth addressing separately, lying flat allows acid to move more freely. One quick check worth building into your evening: if you are eating within two to three hours of lying down, try shifting your last meal earlier. It takes under a minute to look at the time when you sit down to eat and compare it to your usual bedtime. Small adjustments to meal timing and portion size consistently come up in clinical practice as helpful alongside any other management your prescriber recommends. There is more on managing reflux at night on Mounjaro if that is your specific concern.
Most acid reflux on tirzepatide is an inconvenience, not a danger. But some symptoms that can feel like bad indigestion are not. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines, including tirzepatide, specifically highlighting acute pancreatitis: severe, persistent stomach pain that spreads toward the back, with or without vomiting, requires urgent medical assessment rather than self-treatment with antacids. You can report suspected side effects through the MHRA Yellow Card scheme, and doing so helps build the evidence base for everyone using these medicines.
Gallbladder symptoms (pain in the upper right abdomen, sometimes with nausea) are another category that should be checked promptly rather than managed at home. Repeated vomiting severe enough to prevent you keeping fluids down also warrants contact with a healthcare professional, because dehydration puts strain on the kidneys. For practical guidance on reducing acid reflux while on Mounjaro, including positioning, meal habits and when to ask your prescriber about additional support, we have a dedicated page. And if you want a broader read on the mechanism behind these effects, our tirzepatide and acid reflux explainer goes into more detail on the gastric-emptying pathway.
Reflux that does not settle within a couple of weeks, or that noticeably affects your sleep, appetite or daily life, is worth raising. Prescribers have several levers: a slower titration schedule, advice on meal composition and timing, or in some cases a short course of appropriate medication alongside treatment. What they will not do (and should not do) is advise you to simply stop Mounjaro without discussion, because stopping abruptly can have its own consequences for weight management progress.
At nume, every repeat order goes through a fresh clinical review by a GPhC-registered prescriber, not an automated system. Side effects you are experiencing (including reflux) are exactly the kind of thing that review is there to catch and act on. If you are considering starting treatment and want to understand how the process works, our Mounjaro page covers eligibility, the prescription route and what to expect. When you are ready, speaking to our prescribers starts with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.